Healthcare -
Biotechnology - NASDAQ - CA
$ 3.01
-1.95 %
$ 104 M
Market Cap
-2.69
P/E
Price Target
Average
265.45%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
48.33%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Achieve Life Sciences, Inc.
Wall Street analysts predict an average 1-year price target for ACHV of $11 , with forecasts ranging from
a
low of
$11 to a high of $11 .
ACHV Lowest Price Target
Wall Street Target
11 USD
265.45%
ACHV Average Price Target
Wall Street Target
11 USD
265.45%
ACHV Highest Price Target
Wall Street Target
11 USD
265.45%
REVENUE FORECAST
Revenue Forecast Chart ACHV
EBIT FORECAST
EBIT Forecast Chart ACHV
NET INCOME FORECAST
Net Income Chart ACHV